Hsp90 inhibition sensitizes DLBCL cells to cisplatin.
Saved in:
| Title: | Hsp90 inhibition sensitizes DLBCL cells to cisplatin. |
|---|---|
| Authors: | Schmidt, Linnéa1,2 (AUTHOR), Issa, Issa Ismail1,2 (AUTHOR), Haraldsdóttir, Hulda1 (AUTHOR), Hald, Jonas Laugård1 (AUTHOR), Schmitz, Alexander1 (AUTHOR), Due, Hanne1 (AUTHOR), Dybkær, Karen1,2,3 (AUTHOR) k.dybkaer@rn.dk |
| Source: | Cancer Chemotherapy & Pharmacology. Apr2022, Vol. 89 Issue 4, p431-440. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 155956526 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hsp90 inhibition sensitizes DLBCL cells to cisplatin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Schmidt%2C+Linnéa%22">Schmidt, Linnéa</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Issa%2C+Issa+Ismail%22">Issa, Issa Ismail</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haraldsdóttir%2C+Hulda%22">Haraldsdóttir, Hulda</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hald%2C+Jonas+Laugård%22">Hald, Jonas Laugård</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmitz%2C+Alexander%22">Schmitz, Alexander</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Due%2C+Hanne%22">Due, Hanne</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dybkær%2C+Karen%22">Dybkær, Karen</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> k.dybkaer@rn.dk</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Chemotherapy+%26+Pharmacology%22">Cancer Chemotherapy & Pharmacology</searchLink>. Apr2022, Vol. 89 Issue 4, p431-440. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=155956526 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-022-04407-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 431 Titles: – TitleFull: Hsp90 inhibition sensitizes DLBCL cells to cisplatin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schmidt, Linnéa – PersonEntity: Name: NameFull: Issa, Issa Ismail – PersonEntity: Name: NameFull: Haraldsdóttir, Hulda – PersonEntity: Name: NameFull: Hald, Jonas Laugård – PersonEntity: Name: NameFull: Schmitz, Alexander – PersonEntity: Name: NameFull: Due, Hanne – PersonEntity: Name: NameFull: Dybkær, Karen IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 03445704 Numbering: – Type: volume Value: 89 – Type: issue Value: 4 Titles: – TitleFull: Cancer Chemotherapy & Pharmacology Type: main |
| ResultId | 1 |